Cargando…

Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys

Detalles Bibliográficos
Autores principales:	Alkharaan, Hassan, Bayati, Shaghayegh, Hellström, Cecilia, Aleman, Soo, Olsson, Annika, Lindahl, Karin, Bogdanovic, Gordana, Healy, Katie, Tsilingaridis, Georgios, De Palma, Patricia, Hober, Sophia, Månberg, Anna, Nilsson, Peter, Pin, Elisa, Sällberg Chen, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384521/ https://www.ncbi.nlm.nih.gov/pubmed/35859351 http://dx.doi.org/10.1093/infdis/jiac121

Ejemplares similares

Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
por: Alkharaan, Hassan, et al.
Publicado: (2021)

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
por: Healy, Katie, et al.
Publicado: (2022)

Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients
por: Blixt, Lisa, et al.
Publicado: (2021)

Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV
por: Ghorbani, Mahin, et al.
Publicado: (2023)

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
por: Mravinacova, Sara, et al.
Publicado: (2022)

Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
por: Asplund Högelin, Klara, et al.
Publicado: (2021)

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
por: Rudberg, Ann-Sofie, et al.
Publicado: (2020)

Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy
por: Alkharaan, Hassan, et al.
Publicado: (2020)

Differences in risk for SARS-CoV-2 infection among healthcare workers
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
por: Blixt, Lisa, et al.
Publicado: (2022)

Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis
por: Geroldinger-Simić, Marija, et al.
Publicado: (2023)

Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer
por: Gaiser, Rogier Aäron, et al.
Publicado: (2019)

Antibodies to SARS-CoV-2 and risk of past or future sick leave
por: Dillner, Joakim, et al.
Publicado: (2021)

Salivary Antibody Responses to Two COVID-19 Vaccines following Different Vaccination Regimens
por: Alkharaan, Hassan, et al.
Publicado: (2023)

Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer
por: Gaiser, Rogier Aäron, et al.
Publicado: (2019)

Author Correction: Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer
por: Gaiser, Rogier Aäron, et al.
Publicado: (2022)

Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies
por: Healy, Katie, et al.
Publicado: (2020)

Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome
por: Pérez, Dolores, et al.
Publicado: (2018)

Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay
por: Hober, Sophia, et al.
Publicado: (2021)

Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
por: Andersson, Maria, et al.
Publicado: (2023)

B‐cell repopulation dynamics and drug pharmacokinetics impact SARS‐CoV‐2 vaccine efficacy in anti‐CD20‐treated multiple sclerosis patients
por: Asplund Högelin, Klara, et al.
Publicado: (2022)

False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases
por: Kharlamova, Nastya, et al.
Publicado: (2021)

Value-based healthcare translated: a complementary view of implementation
por: Colldén, Christian, et al.
Publicado: (2018)

Salivary IgG levels in neonatal calves and its association to serum IgG: an observational pilot study
por: Johnsen, Julie Føske, et al.
Publicado: (2019)

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
por: Bergman, Peter, et al.
Publicado: (2021)

IgG1 and IgG4 antibodies against Aedes aegypti salivary proteins and risk for dengue infections
por: Cardenas, Jenny C., et al.
Publicado: (2019)

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Eosinophilic granulomatous polyangiitis with IgG4 hypergammaglobulinaemia and salivary gland swelling
por: Takahashi, Koichiro, et al.
Publicado: (2020)

Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR redirection
por: Parrot, Tiphaine, et al.
Publicado: (2021)

Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review
por: Puxeddu, Ilaria, et al.
Publicado: (2018)

Histopathology, salivary flow and ultrasonography of the parotid gland: three complementary measurements in primary Sjögren’s syndrome
por: Mossel, Esther, et al.
Publicado: (2021)

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
por: Havervall, Sebastian, et al.
Publicado: (2021)

Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers
por: Lagerqvist, Nina, et al.
Publicado: (2021)

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
por: Havervall, Sebastian, et al.
Publicado: (2021)

A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells
por: Appelberg, Sofia, et al.
Publicado: (2022)

Complementary measurement of nontyphoidal Salmonella-specific IgG and IgA antibodies in oral fluid and serum
por: Elias, Sean C., et al.
Publicado: (2022)

Salivary IgA and IgG in oral lichen planus and oral lichenoid reactions diseases
por: Ghaleyani, Parichehr, et al.
Publicado: (2012)

Spatial, environmental, and individual associations with Anopheles albimanus salivary antigen IgG in Haitian children
por: Jaramillo-Underwood, Alicia, et al.
Publicado: (2022)

Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer
por: Lei, Bo-Wen, et al.
Publicado: (2019)

The albumin-binding domain as a scaffold for protein engineering
por: Nilvebrant, Johan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9vmj7v3oqn28l33d6pbmvtmaqk